Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

ACAD Acadia Pharmaceuticals Inc

0.59 (2.61%)
Dec 04 2023 - Closed
Delayed by 15 minutes


Draw Mode:

Volume 1,128,866
Bid Price 21.97
Ask Price 23.66
News -
Day High 23.06


52 Week Range


Day Low 22.42
Company Name Stock Ticker Symbol Market Type
Acadia Pharmaceuticals Inc ACAD NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.59 2.61% 23.19 20:00:00
Open Price Low Price High Price Close Price Prev Close
22.52 22.42 23.06 22.85 22.60
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
14,918 1,128,866 $ 22.76 $ 25,688,986 - 14.45 - 33.99
Last Trade Time Type Quantity Stock Price Currency
19:00:19 2 $ 22.80 USD

Acadia Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
3.75B 164.18M - 517.24M -215.98M -1.32 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Acadia Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No ACAD Message Board. Create One! See More Posts on ACAD Message Board See More Message Board Posts

Historical ACAD Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week22.1923.0621.5922.301,067,9101.004.51%
1 Month25.1025.5721.5822.691,219,716-1.91-7.61%
3 Months26.4527.1820.30523.051,629,320-3.26-12.33%
6 Months24.3633.9920.30525.571,591,968-1.17-4.8%
1 Year15.6233.9914.4522.721,517,8587.5748.46%
3 Years53.4957.3412.2422.471,666,429-30.30-56.65%
5 Years20.2258.7212.2427.871,585,3762.9714.69%

Acadia Pharmaceuticals Description

Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.

Your Recent History

Delayed Upgrade Clock